HIV genetic variation is directed and restricted by DNA precursor availability

Journal of Molecular Biology

Volumn 270, Issue 2, 1997, Pages 139-151

  Vartanian, Jean Pierre ^c   Plikat, Uwe ^b   Henry, Michel ^c   Mahieux, Renaud ^c   Guillemot, Laurent ^a   Meyerhans, Andreas ^b   Wain Hobson, Simon ^c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

dNTPs; Genetic variation; Human immunodeficiency virus; Mutation; Reverse transcriptase

Indexed keywords

BETA GALACTOSIDASE; DETERGENT; NUCLEOSIDE; THYMIDINE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; EVOLUTION; GENETIC COMPLEMENTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; VIRAL GENETICS; VIRION; VIRUS MUTATION; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 0030739032     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.1104     Document Type: Article

References (66)

1. Alizon M., Sonigo P., Barre-Sinoussi F., Chermann J. C., Tiollais P., Montagnier L., Wain-Hobson S. Molecular cloning of lymphadenopathy-associated virus. Nature. 312:1984;757-760.
2. Bass B. L. An I for editing. Curr. Biol. 5:1995;598-600.
3. Borman A. M., Quillent C., Charneau P., Kean C. M., Clavel F. A highly defective HIV group O provirus: evidence for the role of local sequence determinants in hypermutation during negative strand DNA synthesis. Virology. 208:1995;601-609.
4. Bronson E. C., Anderson J. N. Nucleotide composition as a driving force in the evolution of retroviruses. J. Mol. Evol. 38:1994;506-532.
5. Brown T. C., Jiricny J. A specific mismatch repair event protects mammalian cells from loss of 5-methylcystosine. Cell. 50:1987;945-950.
6. Cheynier R., Henrichwark S., Hadida F., Pelletier E., Oksenhendler E., Autran B., Wain-Hobson S. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell. 78:1994;373-387.
7. Cohen A., Barankiewicz J., Lederman H. M., Gelfand E. W. Purine and pyrimidine metabolism in human lymphocytes. Regulation of deoxyribonucleotide metabolism. J. Biol. Chem. 258:1983;12334-12340.
8. Dahbo Y., Eriksson S. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine. Eur. J. Biochem. 150:1985;429-434.
9. Diaz L., DeStefano J. J. Strand transfer is enhanced by mismatched nucleotides at the 3′ primer terminus: a possible link between HIV reverse transcriptase fidelity and recombination. Nucl. Acids Res. 24:1996;3086-3092.
10. Felder M. P., Laugier D., Yatsula B., Dezélée P., Calothy G., Marx M. Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J. Virol. 68:1994;4759-4767.
11. Fitzgibbon J. E., Mazar S., Dubin D. T. A new type of G→A hypermutation affecting human immunodeficiency virus. AIDS Res. Hum. Retroviruses. 9:1993;833-838.
12. Gao F., Yue L., White A. T., Pappas P. G., Barchue J., Hanson A. P., Greene B. M., Sharp P. M., Shaw G. M., Hahn B. H. Human infection by genetically diverse SIVsm-related HIV-2 in West Africa. Nature. 358:1992;495-499.
13. Gessain A., Gallo R. C., Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J. Virol. 66:1992;2288-2295.
14. Gojobori T., Li W.-H., Graur D. Patterns of nucleotide substitution in pseudogenes and functional genes. J. Mol. Evol. 18:1982;360-369.
15. Goodenow M., Huet T., Saurin W., Kwok S., Sninsky J., Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. Acquir. Immune Def. Syndr. 2:1989;344-352.
16. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1993;1945-1951.
17. Günther S., Sommer G., Plikat U., Iwanska A., Wain-Hobson S., Will H., Meyerhans A. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G → A hypermutation. Virology. 1997;in the press.
18. Hirsch V., Riedel N., Mullins J. I. The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. Cell. 49:1987;307-319.
19. Isel C., Lanchy J. M., Le Grice S. F. J., Ehresmann C., Ehresmann B., Marquet R. Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNAlys3. EMBO J. 15:1996;917-924.
20. Johnson P. R., Hamm T. E., Goldstein S., Kitov S., Hirsch V. M. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques. Virology. 185:1991;217-228.
21. Katz R. A., Skalka A. M. Generation of diversity in retroviruses. Annu. Rev. Genet. 24:1990;409-445.
22. Kazanji M., Moreau J. P., Mahieux R., Bonnemains B., Bomford R., Gessain A., de Thé G. HTLV-1 infection in squirrel monkeys (Sämiri Sciureus) using autologous, homologous or heterologous HTLV-1-transformed cell lines. Virology. 231:1997;258-266.
23. Kim S., Byrn R., Groopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:1989;3708-3713.
24. Kim T., Mudry R. A. Jr, Rexrode C. A. II, Pathak V. K. Retroviral mutation rates and A-to-G hupermutations during different stages of retroviral replication. J. Virol. 70:1996;7594-7602.
25. Krawczak M., Smith-Sorensen B., Schmidtke J., Kakkar V. V., Cooper D. N., Hovig E. Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and selection. Human Mutation. 5:1995;48-57.
26. Kresnak M. T., Davidson R. L. Thymidine-induced mutations in mammalian cells: sequence specificity and implications for mutagenesis in vivo. Proc. Natl Acad. Sci. USA. 89:1992;2829-2833.
27. Kunz B., Kohalmi S. Modulation of mutagenesis by deoxynucleotide levels. Annu. Rev. Genet. 25:1991;339-359.
28. Li W.-H., Wu C.-I., Luo C.-C. Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications. J. Mol. Evol. 21:1984;58-71.
29. Mansky L. L., Temin H. M. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68:1994;494-499.
30. Mansky L. M., Temin H. M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:1995;5087-5094.
31. Martinez M. A., Vartanian J. P., Wain-Hobson S. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl Acad. Sci. USA. 91:1994;11787-11791.
32. Martinez M. A., Sala M., Vartanian J. P., Wain-Hobson S. Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucl. Acids Res. 14:1995;2573-2578.
33. Mathews C. K., Ji J. DNA precursor asymmetries, replication fidelity, and variable genome evolution. BioEssays. 14:1992;295-301.
34. Meuth M. The molecular basis of mutations induced by deoxynucleoside triphosphate pool imbalances in mammalian cells. Expt. Cell. Res. 181:1989;305-316.
35. Meyerhans A., Vartanian J. P., Hultgren C., Plikat U., Karlsson A., Wang L., Eriksson S., Wain-Hobson S. Restriction and enhancement of HIV-1 replication by modulation of intracellular dNTP pools. J. Virol. 68:1994;535-540.
36. Myers G., Korber B., Hahn B. H., Jeang K. T., Mellors J. W., McCutchen F. E., Henderson L. E., Pavlakis G. N. Human Retroviruses and AIDS. 1995;Los Alamos National Laboratory, Los Alamos.
37. Parthasarathi S., Varela-Echavarria A., Ron Y., Preston B. D., Dougherty J. P. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:1995;7991-8000.
38. Pathak V. K., Temin H. M. Broad spectrum of in vitro forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl Acad. Sci. USA. 87:1990a;6024-6028.
39. Pathak V. K., Temin H. M. Broad spectrum of in vitro forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc. Natl Acad. Sci. USA. 87:1990b;6019-6023.
40. Perry S. T., Flaherty M. T., Kelley M. J., Clabough D. L., Tronick S. R., Coggins L., Whetter L., Lengel C. R., Fuller F. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro. J. Virol. 66:1992;4085-4097.
41. Phear G., Nalbantoglu J., Meuth M. Next-nucleotide effects in mutations driven by DNA precursor pool imbalances at the aprt locus of Chinese hamster ovary cells. Proc. Natl Acad. Sci. USA. 84:1987;4450-4454.
42. Preston B. D., Dougherty J. P. Mechanisms of retroviral mutation. Trends Microbiol. 4:1996;16-21.
43. Pusinelli G. A., Temin H. M. Characterization of large deletions occuring during a single round of retrovirus replication: novel deletion mechanism involving errors in strand transfer. J. Virol. 65:1991;4786-4797.
44. Reichard P. Interactions between deoxynucleotide and DNA synthesis. Annu. Rev. Biochem. 57:1988;349-374.
45. Reichard P. From RNA to DNA, why so many ribonucleotide reductases? Science. 260:1993;1773-1777.
46. Ripley L. S. Frameshift mutation: determinants of specificity. Annu. Rev. Genet. 24:1990;189-213.
47. tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study. EMBO J. 14:1995;4622-4627.
48. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl Acad. Sci. USA. 80:1983;3618-3622.
49. Seillier-Moiseiwitsch F., Margolin B. H., Swanstrom R. Genetic variability of the human immunodeficiency: statistical and biological issues. Annu. Rev. Genet. 28:1994;559-596.
50. Slabaugh M. B., Howell M. L., Wang Y., Mathews C. K. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth. J. Virol. 65:1991;2290-2298.
51. Sommer B., Köhler M., Sprengel R., Seeburg P. H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell. 67:1991;11-19.
52. Suzuki T., Kitao S., Matsushime H., Yoshida M. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15:1996;1607-1614.
53. Tattersall M. H. N., Ganeshaguru K., Hoffbrand A. V. The effect of external deoxyribonucleosides on deoxynucleoside triphosphate concentrations in human lymphocytes. Biochem. Pharmacol. 24:1975;1495-1498.
54. Tiollais P., Buendia M. A. Hepatitis B virus. Scient. Am. 264:1991;116-123.
55. Tyrsted G. Effect of hydroxyurea and 5-fluorodeoxyuridine on deoxyribonucleoside triphosphate pools early in phytohemagglutinin-stimulated human lymphocytes. Biochem. Pharmacol. 31:1982;3107-3113.
56. Varela-Echavarria A., Garvey N., Preston B. D., Dougherty J. P. Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J. Biol. Chem. 267:1992;24681-24688.
57. Varela-Echavarria A., Prorock C. M., Ron Y., Dougherty J. P. High rate of genetic rearrangements during replication of a Moloney murine leukemia virus-based vector. J. Virol. 67:1993;6357-6364.
58. Vartanian J. P., Meyerhans A., Åsjö B., Wain-Hobson S. Selection, recombination and G > A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1991;1779-1788.
59. Vartanian J. P., Meyerhans A., Sala M., Wain-Hobson S. G→A hypermutation of the HIV-1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc. Natl Acad. Sci. USA. 91:1994;3092-3096.
60. Wain-Hobson S. Running the gamut of retroviral variation. Trends Microbiol. 4:1996;135-141.
61. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 40:1985;9-17.
62. Wain-Hobson S., Vartanian J. P., Henry M., Chenciner N., Cheynier R., Delassus S., Pedroza Martins L., Sala M., Nugeyre M. T., Guétard D., Klatzmann D., Gluckman J. C., Rozenbaum W., Barré-Sinoussi F., Montagnier L. LAV revisited: origins of the early HIV isolates from Institut Pasteur. Science. 252:1991;961-965.
63. Wain-Hobson S., Sonigo P., Guyader M., Gazit A., Henry M. Erratic G→A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. Virology. 209:1995;297-303.
64. Wattel E., Vartanian J. P., Pannetier C., Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69:1995;2863-2868.
65. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. Y. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61:1990;213-222.
66. Zack J. A., Haislip A. M., Krogstad P., Chen I. S. Y. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1992;1717-1725.